SIHUAN PHARM
- Country
- 🇨🇳China
- Ownership
- Public
- Established
- 2010-10-06
- Employees
- 2.6K
- Market Cap
- -
- Website
- http://www.sihuanpharm.com
- Introduction
Sihuan Pharmaceutical Holding Group Co., Ltd. (“Sihuan Pharmaceutical” or the “Company”, together with its subsidiaries is the “Group”) (stock code: 00460.HK) was founded in 2001 and listed on the main board of the Hong Kong Stock Exchange Limited in 2010. It is an international medical, aesthetic and biopharmaceutical enterprise with an independent and lead...
XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer
- First Posted Date
- 2020-11-09
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT04622072
- Locations
- 🇨🇳
Henan cancer hospital, Zhengzhou, Henan, China
🇨🇳Cancer hospital Chinese academy of medical sciences, Beijing, Beijing, China
🇨🇳Beijing cancer hospital, Beijing, Beijing, China
A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2020-09-07
- Last Posted Date
- 2020-09-07
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT04539496
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)
- Conditions
- Interventions
- First Posted Date
- 2020-08-10
- Last Posted Date
- 2020-08-10
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 112
- Registration Number
- NCT04505683
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers.
- Conditions
- Interventions
- First Posted Date
- 2020-08-07
- Last Posted Date
- 2020-08-07
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT04503629
- Locations
- 🇨🇳
The Fisrst Affiliated Hospital of NanChang University, Nanchang, Jiangxi, China
Open-label Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of a Single Oral Dose of [14C]-20 mg/100 μCi Anaprazole Sodium Enteric-coated Capsule in Healthy Adult Male Subjects
- Conditions
- Interventions
- First Posted Date
- 2020-07-20
- Last Posted Date
- 2020-07-20
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT04476394
Pharmacokinetics of Benapenem in Subjects With Renal Impairment
- First Posted Date
- 2020-07-20
- Last Posted Date
- 2020-07-20
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT04476407
- Locations
- 🇨🇳
Shanghai Tongji Hospital, Shanghai, Shanghai, China
A Multiple Ascending High Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
- Conditions
- Interventions
- First Posted Date
- 2020-07-15
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT04471922
- Locations
- 🇨🇳
Chinese PLA General Hospital, Beijing, Beijing, China
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
- Conditions
- Interventions
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2020-07-10
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT04466748
Evaluate the Effects of Food on the Pharmacokinetics of Fadanafil in Healthy Subjects
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2020-07-10
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT04467203
- Locations
- 🇨🇳
Haiyan Li, Beijing, Beijing, China
A Single Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2020-07-10
- Lead Sponsor
- Sihuan Pharmaceutical Holdings Group Ltd.
- Target Recruit Count
- 74
- Registration Number
- NCT04467060